首页> 外文期刊>Morbidity and mortality weekly report >Global Measles and Rubella Laboratory Network, January 2004-June 2005.
【24h】

Global Measles and Rubella Laboratory Network, January 2004-June 2005.

机译:2004年1月至2005年6月,全球麻疹和风疹实验室网络。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Measles continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries. In 2000, measles was considered the fifth leading cause of childhood mortality, and the World Health Organization (WHO) estimated that approximately 777,000 measles-associated deaths occurred worldwide. In 2001, WHO and the United Nations Children's Fund (UNICEF) developed a 5-year strategic plan, endorsed by the World Health Assembly in 2003, to reduce measles mortality by 50% by 2005 (relative to 1999 estimates) and to achieve and maintain interruption of indigenous measles transmission in large geographic areas with established measles elimination goals. This plan included strengthening routine vaccination coverage, providing a second opportunity for measles immunization to children, improving measles case management, and improving surveillance with laboratory confirmation of suspected measles cases. To date, four of six WHO regions have established measles elimination targets: the Americas Region (AMR) by 2000, the European Region (EUR) by 2010, the Eastern Mediterranean Region (EMR) by 2010, and the Western Pacific Region (WPR) by 2012. The remaining two WHO regions, the African (AFR) and South East Asian (SEAR) regions, are continuing work toward the measles mortality reduction goal. Likewise, to reduce the burden of disease from congenital rubella syndrome (CRS), currently estimated at 100,000 cases per year worldwide, several countries have developed or continue to develop rubella control programs, and AMR and EUR have established regional rubella elimination and CRS reduction goals, respectively. Because improved global surveillance is essential for monitoring progress toward mortality reduction and elimination of these diseases, WHO established the Measles and Rubella Laboratory Network (LabNet) in 2003 to promote case identification and confirmation. This report provides an update on the development of LabNet during January 2004-June 2005 and describes the geographic distribution of measles and rubella virus genotypes as of June 2005.
机译:麻疹仍然是发展中国家儿童发病率和死亡率的主要原因,并且在大多数国家中是爆发威胁的原因。 2000年,麻疹被认为是造成儿童死亡的第五大原因,世界卫生组织(WHO)估计,全世界约有777,000例麻疹相关死亡。 2001年,世卫组织和联合国儿童基金会(儿童基金会)制定了一项为期5年的战略计划,该计划于2003年获得世界卫生大会的批准,到2005年将麻疹死亡率降低50%(相对于1999年的估计数),并实现和维持在既定的消灭麻疹目标的情况下,在较大的地理区域内中断本地麻疹的传播。该计划包括加强常规疫苗接种覆盖率,为儿童提供第二次麻疹疫苗接种机会,改善麻疹病例管理以及通过实验室确认可疑的麻疹病例来改善监测。迄今为止,世卫组织六个区域中的四个已经制定了消除麻疹的目标:到2000年的美洲地区(AMR),到2010年的欧洲地区(EUR),到2010年的东地中海地区(EMR)和西太平洋地区(WPR)到2012年。世界卫生组织的其余两个区域,即非洲(AFR)和东南亚(SEAR)地区,正在继续朝着降低麻疹死亡率的目标努力。同样,为减轻先天性风疹综合症(CRS)的疾病负担,目前全球每年估计有100,000例病例,一些国家已经制定或继续制定风疹控制计划,AMR和EUR已制定了消除地区风疹和降低CRS的目标, 分别。由于改进的全球监测对于监测降低死亡率和消除这些疾病的进展至关重要,因此世卫组织于2003年建立了麻疹和风疹实验室网络(LabNet),以促进病例的识别和确认。本报告提供了2004年1月至2005年6月LabNet的最新发展情况,并描述了截至2005年6月麻疹和风疹病毒基因型的地理分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号